Do women in the Valencian Community accept self-sampling as a form of cervical cancer screening?
Por:
Besó Delgado M, Ibáñez Cabanell J, Molina-Barceló A, Zurriaga Llorens O and Salas Trejo D
Publicada:
26 ene 2021
Ahead of Print:
26 ene 2021
Resumen:
Background: The use of new devices such as the self-sampli for the determination of the Human Papilloma Virus (HPV), could facilitate the implementation of population screening programs and increase the participation of women. The objective of the study was to find out the women's knowledge and attitudes towards cervical cancer screening as well as the acceptability of self-sampling.
Methods: Analytical cross-sectional study by telephone survey carried out on a random sample of 389 women from 35 to 65 years of age. The women were asked about their atfitudes and knowledge of the screening and preference for I IPV determination by self-sampling or by a healthcare professional.
Results: 86.9% of the women preferred self-sampling as a screening method and 93.3% had undergone a previous cervical cytology. 51.4% of the women had a high level of knowledge about cervical cancer screening. Younger women (POR 9.26; 954/0 CI 1.04-24.38), higher level of education (POR 4.6; 95% CI: 1.92-11.00), and higher level of knowledge (POR 2.78; 95% CI: 1.0-9.29), presented higher preferences for the determination of HPV by self-sampling. The trend in age, educational level and knowledge was the same for the prevalence of previous cervical cytology.
Conclusions: The acceptance of self-testing as a method of cervical cancer screening is high among women. Efforts should be made to raise awareness among women to reduce possible inequalities in access and to encourage informed participation.
Filiaciones:
:
Servicio de Prevención y Promoción en el Entorno Sanitario. Dirección General de Salud Pública. Valencia. España
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO. Área de Cáncer y Salud Pública. Valencia. España
:
Servicio de Prevención y Promoción en el Entorno Sanitario. Dirección General de Salud Pública. Valencia. España
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO. Área de Cáncer y Salud Pública. Valencia. España
:
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO. Área de Cáncer y Salud Pública. Valencia. España
:
Departamento de Medicina Preventiva y Salud Pública. Ciencias de la Alimentación, Toxicología y Medicina Legal. Universidad de Valencia. Valencia. España
Dirección General de Salud Pública. Generalitat Valenciana. Valencia. España
CIBER de Epidemiología y Salud Pública. España
Unidad Mixta de Investigación en Enfermedades Raras. FISABIO-UVEG. Valencia. España
:
Servicio de Prevención y Promoción en el Entorno Sanitario. Dirección General de Salud Pública. Valencia. España
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO. Área de Cáncer y Salud Pública. Valencia. España
Open Access
|